Difficulty: Medium
Average Score: 86%
Practice
What monoclonal antibody is used to prevent respiratory syncytial virus (RSV) in high-risk children?
Correct answer
A
Rationale
The correct answer is A: Palivizumab. Palivizumab is used to prevent RSV in high-risk children by targeting the RSV F protein, reducing the severity of infection. Natalizumab (B) is used for multiple sclerosis, Belimumab (C) is for systemic lupus erythematosus, and Eculizumab (D) is for atypical hemolytic uremic syndrome, making them incorrect choices for preventing RSV.